Page last updated: 2024-11-07

meglumine iotroxinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

meglumine iotroxinate: Contrast media for intravenous cholecystography [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119297
CHEMBL ID4297078
MeSH IDM0059368

Synonyms (21)

Synonym
meglumine iotroxate
iotroxate meglumine
D03902
biliscopin dic (tn)
d-glucitol, 1-deoxy-1-(methylamino)-, 3,3'-(oxybis(2,1-ethanediyloxy(1-oxo-2,1-ethanediyl)imino))bis(2,4,6-triiodobenzoate) (2:1) (salt)
unii-389136rro0
sh 273
iotroxic acid meglumine
meglumine iotroxinate
68890-05-1
chologram3,3'-(trioxaundecadioyldiamino)-bis-2,4,6-triiodobenzoic acid meglumine
389136rro0 ,
iotroxin acid meglumine
iotroxamide
iotroxate meglumine [who-dd]
iotroxate meglumine [jan]
d-glucitol, 1-deoxy-1-(methylamino)-, 3,3'-(oxybis(2,1-ethanediyloxy(1-oxo-2,1-ethanediyl)imino))bis(2,4,6-triiodobenzoate) (2:1)
DTXSID80218969
Q27256767
CHEMBL4297078
3-[[2-[2-[2-[2-(3-carboxy-2,4,6-triiodoanilino)-2-oxoethoxy]ethoxy]ethoxy]acetyl]amino]-2,4,6-triiodobenzoic acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (51.43)18.7374
1990's8 (22.86)18.2507
2000's5 (14.29)29.6817
2010's4 (11.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.19 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials9 (20.93%)5.53%
Reviews3 (6.98%)6.00%
Case Studies4 (9.30%)4.05%
Observational0 (0.00%)0.25%
Other27 (62.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]